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The status anxiety hypothesis proposes that systematic inflammation as a consequence of chronic 
psycho-social stress is a possible pathway linking socio-economic position (SEP) to premature 
ageing and is a possible explanation for cross-national variation in patterns of health and well-being. 
Harmonised data from the LIFEPATH consortium on 18,349 individuals aged 50 to 75 and 30,632 
observations are used to measure variation in the association between inflammation measured as 
C-reactive protein and SEP across four countries (Britain, Ireland, Portugal and Switzerland) and five 
studies (ELSA, Whitehall II, TILDA, EPIPorto and SKIPOGH). Adjusting for population composition, 
mean concentrations of CRP are highest in Portugal, the country with the highest income inequality 
and lowest in Switzerland, a lower income inequality country. Across all of the studies, lower SEP 
groups have higher mean concentrations of CRP and, as predicted by the theory, absolute differentials 
between SEP groups reflect the pattern of societal income inequality. Adjustment for lifestyle indicators 
reduces SEP differentials by between 45% and 52% but cannot account for country variation in mean 
inflammation.
The ‘inverse health gradient’ between socioeconomic position (henceforce SEP), health and life expectancy is 
now a well-established fact across all societies where evidence has been collected1. Irrespective of the measure of 
SEP used (income, education, social class or status), socially and economically disadvantaged individuals have a 
shorter life expectancy and worse health during life2. The gradient in health emerges early in childhood and gets 
steeper with age3,4.
SEP determines the level of resources available to individuals and households, influencing biological function 
via the material environment, e.g. the location and quality of housing and exposure to pollutants, damp and 
microbial load5 as well as health behaviours6 but it is becoming increasingly clear that SEP may also shape biolog-
ical health via neurological and hormonal pathways7. Under this paradigm, chronic psycho-social stress caused 
by economic strain8, uncertainty and lack of control9 or threats to social status and social threat10–12 are purported 
to cause SEP inequalities in health either directly or indirectly via adverse health behaviours. The direct pathway 
occurs through activation of glucocorticoid and adrenergic signalling pathways13,14 that, amongst other conse-
quences, result in a chronic inflammatory response. There are now a number of studies which provide evidence 
of an association between SEP and systematic inflammation in adulthood15–19. A possible physiological process 
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mediating the association between chronic psycho-stress and inflammation has been shown by Tawakol et al.20. 
Raised amygdala activation increases haemopoietic activity and arterial inflammation leading to an elevated risk 
of cardiovascular events. The same underlying process has been shown to contribute to the risk of other diseases 
such as type 2 diabetes21 and cancer22.
The emerging link between psycho-social stress and disease has also been put forward as an explanation for 
the pattern of cross-national variation in health and well-being23–26. Proponents of this hypothesis, known as the 
status anxiety hypothesis, argue that, irrespective of national wealth, all developed societies exhibit a gradient in 
levels of morbidity and mortality by SEP rather than a step-function between advantaged and disadvantaged. 
Absolute variation in morbidity and mortality across societies is more strongly correlated with level of income 
inequality than to gross domestic product per capita; among rich developed countries, differences in income and 
wealth matter less than how they are distributed across the population. Proponents of the status anxiety hypoth-
esis put forward three linked propositions. First, that human social psychology was shaped by evolution which 
occurred almost entirely within hunter-gather societies with limited inequalities in material standard of living 
and social status27. Second, that income inequality is one measure of a society’s hierarchy of social status and third, 
that more inequality in the distribution of income and other scarce resources28, leads to increased psycho-social 
stress at the individual level at all points in the SEP distribution with consequences for health and well-being. If 
true, this hypothesis would imply that the differential between low and high SEP in status anxiety, psycho-social 
stress and inflammation will be positive with income inequality. Another implication is that everyone experiences 
higher psycho-social stress and inflammatory response in more unequal societies, not just those in the lowest SEP.
The extent of perceived status anxiety has been shown to vary significantly across European countries by 
SEP28,29 and more unequal countries (as measured by income inequality) have larger differentials in perceived 
status anxiety by SEP29,30 and worse mental health30. Moreover, more unequal countries have higher status anxiety 
overall. The highest SEP groups in more unequal societies have similar levels of status anxiety to the lowest SEP 
groups in more equal societies29. However, to date, there have been no studies comparing SEP differentials in 
inflammation across countries which vary by level of income inequality. If the status anxiety hypothesis is correct, 
higher income inequality should be associated with larger social differentials in inflammation between SEP and 
a higher mean level of inflammation. Alternative hypotheses for the association between income inequality and 
health have been proposed which would not implicate psycho-social stress and inflammation30–32 but evidence 
of social structuring of inflammation by SEP and country inequality would be supportive of the status anxiety 
hypothesis.
However, average levels of inflammation could also vary within and between societies as a function of health 
behaviours. Chronic psycho-social stress has been shown to promote behaviours with adverse effects on health 
such as smoking, poor diet and excess alcohol consumption9 and these variables have been shown to be a media-
tor between SEP and inflammation16,17,19,33.
In this paper, we examine the prediction of the status anxiety hypothesis that countries with higher income ine-
quality will have larger differentials in inflammation by SEP as well as higher average levels of inflammation in the 
population overall. Ideally, we would use individual level data with information on SEP, perceived status anxiety, 
inflammatory markers and lifestyle indicators for a large number of countries which differ in terms of income ine-
quality, preferably measured with repeated observations over time. Unfortunately, such data are not available at 
present; instead, we draw on harmonised data on SEP (European Socio-economic Classification - EsEC), inflam-
mation (C-reactive protein concentration – henceforth CRP) and lifestyle factors (smoking, body-mass index, 
diabetes & hypertension) from the LIFEPATH Project, an EC Horizon 2020 consortium, to carry out a more 
limited examination of the hypothesis in four European countries: Britain, Ireland, Portugal and Switzerland. 
Figure 1 shows that these countries have consistently had different levels of income inequality with Portugal hav-
ing the highest average income inequality (measured using the GINI coefficient) at 34.5, followed by the United 
Kingdom at 33.2, Ireland at 30 and Switzerland at 29.6. These country differences in levels of income inequality 
are relatively muted in comparison to other nations. For example, the USA has a GINI coefficient of 45 compared 
to Sweden at 24.9. This would imply that our test of the status anxiety hypothesis is relatively conservative and 
more likely to produce a null-finding compared a test using countries which vary more in their levels of income 
inequality.
Figure 1. GINI Coefficient (Income Inequality) by Year and Country.
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Data from The English Longitudinal Study of Ageing34 (ELSA) and the Whitehall II Study35 are used for the 
UK, The Irish Longitudinal Study of Ageing36 (TILDA) is used for Ireland, The Swiss Kidney Project on Genes 
and Hypertension37 (SKIPOGH) for Switzerland and the EPIPorto Study38 for Portugal.
Results
Of the 34262 individuals who participated across the five studies, varying proportions contributed blood samples 
for the collection of CRP. This proportion varied from 39% in EPIPorto to 77% in ELSA. To provide comparative 
samples across studies, individuals aged between 50 and 75 were selected, reducing the sample to 19,018 indi-
viduals overall with at least one CRP sample. Given our focus on chronic inflammation, participants with CRP 
levels higher than 10 mg/L were excluded from the analysis sample as this could indicate the presence of an acute 
illness, reducing the sample to 18,349 individuals. Inclusion of multiple observations per person for some samples 
(Whitehall, SKIPOGH, ELSA) provides 30,632 observations overall. Table 1 provides the distribution of individ-
ual characteristics for the sample of individuals by study. The distribution of SEP indicators across countries has 
important implications for the distribution of lifestyle factors and the patterning of CRP. Three of the samples 
for analysis (SKIPOGH, TILDA and ELSA) have approximately equal proportions of men and women whereas 
the EPIPorto sample is 64% female and Whitehall II 69% male. EPIPorto has a higher proportion of the lowest 
social class (56%) and education groups (72%) compared to the other studies which may lead to higher overall 
levels of inflammation. The Whitehall II study population is more advantaged in its socio-economic profile. The 
distribution of lifestyle indicators vary widely across countries: 33% of the TILDA sample are measured as obese 
compared to just over 18% in Whitehall II and 17% in SKIPOGH. To ensure that the samples are compared on 
EPIPorto Whitehall SKIPOGH TILDA ELSA
N Individuals 817 7,175 487 4,570 5,300
N Observations 817 13,733 813 4,570 10,699
N (%) N (%) N (%) N (%) N (%)
Socioeconomic Position
Most Recent Social Class
High Class 146 17.9 3,832 53.4 112 23.0 1,549 33.9 1,341 25.3
Med. Class 211 25.8 2,191 30.5 169 34.7 1,105 24.2 2,259 42.6
Low Class 460 56.3 1,152 16.1 206 42.3 1,916 41.9 1,700 32.1
Highest Education
High Education 139 17.0 2,449 34.3 87 17.9 785 17.2 798 15.3
Med. Education 91 11.1 1,919 26.9 145 29.8 1,676 36.7 1,180 22.6
Low Education 587 71.9 2,764 38.8 255 52.4 2,109 46.2 3,243 62.1
Demographics
Sex
Men 295 36.1 4,974 69.3 221 45.4 2,148 47.0 2,445 46.1
Women 522 63.9 2,201 30.7 266 54.6 2,422 53.0 2,855 53.9
Age Groups
Age 50–54 204 25.0 2,714 37.8 135 27.7 1,071 23.4 669 12.6
Age 55–59 185 22.6 2,409 33.6 102 20.9 1,124 24.6 1,493 28.2
Age 60–64 162 19.8 1,213 16.9 78 16.0 949 20.8 1,100 20.8
Age 65–69 142 17.4 662 9.2 95 19.5 789 17.3 1,076 20.3
Age 70–74 124 15.2 177 2.5 77 15.8 637 13.9 962 18.2
Lifestyle Indicators
Body Mass Index
Healthy Weight 227 27.9 2,463 35.8 211 43.3 1,006 22.1 1,309 26.3
Overweight 380 46.7 3,193 46.4 195 40.0 2,049 44.9 2,258 45.3
Obese 207 25.4 1,220 17.7 81 16.6 1,507 33.0 1,414 28.4
Diabetes
No 723 88.5 6,761 95.3 471 96.7 4,284 93.7 4,313 94.2
Yes 94 11.5 337 4.8 16 3.3 286 6.3 268 5.9
Tobacco Consumption
Never Smoker 531 65.2 3,237 47.7 209 42.9 2,081 45.5 2,208 41.7
Past Smoker 186 22.9 2,638 38.9 194 39.8 1,747 38.2 2,296 43.3
Current Smoker 97 11.9 913 13.5 84 17.3 742 16.2 794 15.0
Hypertension
No 340 41.6 5,625 78.5 404 83.0 4,262 93.3 3,196 62.8
Yes 477 58.4 1,538 21.5 83 17.0 308 6.7 1,891 37.2
Table 1. Final Sample Characteristics by Study (of individuals).
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a common basis, sample weights are used to create equal sample distributions for each of the studies by sex, age 
group and SEP. Distributions of individuals by sex, age and SEP are thus identical across samples in analyses.
Descriptive Differentials in CRP Concentration. Using weights to adjust for sample composition across 
studies, mean observed CRP concentration is significantly higher for low SEP compared to high SEP in all studies 
and across the age range, although the pattern is less distinct for SKIPOGH (Table 2), for the contrast between 
medium SEP and high and when education is the SEP measure. Being overweight and particularly being defined 
as obese, is associated with a significantly higher CRP than among those who are healthy weight. The abso-
lute increase in CRP with obesity is higher than when the individual is overweight. The pattern of increases in 
CRP with indications for diabetes and hypertension are more mixed with consistent, significant differences in 
Whitehall II and ELSA but not in the other studies. Being a current daily smoker is associated with a significantly 
higher mean CRP, although not in EPIPorto. Women have higher mean CRP at all ages and across studies.
Predicted Country Differentials in CRP Concentration by Study. Using weights to adjust for sample 
composition across studies (Fig. 2), predicted mean concentrations of CRP are highest in EPIPorto (2.42 mg/L: 
95% CI 2.24–2.59) and ELSA (2.42 mg/L: 95% CI 2.37–2.47) and lowest in SKIPOGH (1.87 mg/L: 95% CI 
1.71–2.04) with the lower mean concentrations for Whitehall II and SKIPOGH significantly lower than those 
for EPIPorto and ELSA (P < 0.001). Between study variations in absolute mean CRP concentration falls with 
age and all mean differences in CRP between studies become insignificant by age 70. Confidence intervals for 
mean CRP concentration for EPIPorto, ELSA and TILDA overlap, but the pattern of study differences in mean 
CRP is broadly in line with the hypothesis that the country with the highest overall income inequality (Portugal/
EPIPorto) will have higher average levels of inflammation compared to the country with the lowest (Switzerland/
SKIPOGH).
Predicted Absolute Differentials in CRP Concentration. Table 3, Panel A provides the estimated CRP 
concentrations (mg/L) by SEP obtained from the weighted generalized linear models with terms for age, sex, 
study and interactions of study, SEP and sex with polynomials of age. These confirm that across the studies, the 
low and middle SEP have significantly higher concentrations of CRP compared to the high SEP in all studies. 
Absolute differentials between low SEP and high SEP are largest in EPIPorto (0.52 mg/L: 95% CI 0.37–0.68) and 
lowest in SKIPOGH (0.27 mg/L: 95% CI 0.23–0.3).
Predicted SEP differentials by age vary across studies (Fig. 3a,b). In all studies except EPIPorto, absolute dif-
ferentials between low and high SEP groups fall with age and lowest in TILDA then SKIPOGH from age 60. The 
low-high SEP differential for EPIPorto on the other hand increases steeply with age from 0.14 mg/L at 50 (95% 
CI: 0 to 1.39) to 1 mg/L at 75 (95% CI: 0 to 2.76) although wide confidence intervals for the SEP differential in 
EPIPorto mean that the pattern could logically also be decreasing rather than increasing.
Figure 4a–e show the predicted age trajectories of CRP by SEP for the five studies and illustrate why the SEP 
differential with age is different for EPIPorto. In that study, CRP rises for both low and high SEP, but the increase 
is steeper for the low SEP group.
Relative SEP Differentials in CRP Concentration. Relative SEP differentials (low/high SEP - Table 3, 
Panel A) are lowest in SKIPOGH (116%: 95% CI 111–118%) and highest in Whitehall II (130%: 95% CI 122–
124%) and EPIPorto (125%: 95% CI 113–128%). The pattern of relative SEP differentials by age largely mirrors 
the pattern of absolute differentials by age (Fig. 5a,b) with decreases across all studies except EPIPorto, although, 
wide confidence intervals make interpretation problematic.
SEP Differentials in CRP Concentration Adjusting for Lifestyle Factors. To examine the extent to 
which study and SEP differentials can be accounted for by differences in lifestyle behaviours across samples and 
groups, generalised linear models were estimated adjusting for the base model and lifestyle factors (Table 3, Panel 
B). With adjustment, both absolute and relative differentials in CRP between low, middle and high SEP groups 
fall but the differentials between low/middle and high SEP groups remains significant. The relative differential 
between low and high SEP groups after adjustment for lifestyle factors is lowest in SKIPOGH (104%: 95% CI 0% 
to 109%) and highest in Whitehall II (117%: 95% CI 114% to 116%).
Figure 6 gives the reduction in relative differential between low and high SEP groups by the addition of life-
style variables for each study. Single adjustment for BMI produces the largest reduction in differential (between 
31% and 37% across studies). Adjusting for all of the lifestyle factors simultaneously decreases the low – high SEP 
differential by between 45% (EPIPorto) and 52% (SKIPOGH).
Discussion
This paper provides new insight into the validity of the status anxiety hypothesis using biological data on inflam-
mation measured as C-reactive protein. The hypothesis proposes that variation in income inequality between 
societies explains cross-national variation in differentials in health between SEP groups as well as at least some 
cross-national variation in population health. According to the hypothesis, societies which have larger social 
status differentials or which put more emphasis on social status will induce higher average levels of psycho-social 
stress with damaging biological consequences through activation of glucocorticoid and adrenergic signalling 
pathways13,14 that result in a chronic inflammatory response. Using data from five large cohort studies from four 
European countries we tested whether countries with higher income inequality will have higher average levels of 
inflammation and greater differentials in inflammation by SEP.
Overall, our findings support the predictions of the hypothesis: after constraining the samples to have the 
same age, sex and SEP distributions, mean concentrations of CRP are highest in Portugal, the country with the 
highest income inequality and lowest in Switzerland, the lower income inequality country, although country 
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Characteristic Study Age Group
50–54 55–59 60–64 65–69 70–75
Social Class
Low
v Social Class High
EPIPorto −0.01 0.54 0.70 0.96 0.63
Whitehall 0.58 0.62 0.71 0.60 1.02
SKIPOGH 0.02 0.75 −0.14 0.55 −0.18
TILDA 0.33 0.45 0.28 0.30 0.55
ELSA 0.42 0.59 0.63 0.53 0.28
Social Class
Medium
v Social Class High
EPIPorto −0.24 0.88 −0.14 0.05 0.54
Whitehall 0.29 0.30 0.36 0.60 0.66
SKIPOGH 0.24 0.37 −0.20 0.77 0.11
TILDA 0.22 0.14 0.12 −0.05 0.69
ELSA −0.16 0.31 0.16 0.32 0.09
Education
Low v Highest Education High
EPIPorto −0.03 0.36 1.00 1.54 0.68
Whitehall 0.26 0.33 0.36 0.38 0.50
SKIPOGH 0.92 0.76 0.29 0.37 0.01
TILDA 0.27 0.71 0.51 0.08 0.68
ELSA 0.63 0.56 0.79 0.69 0.42
Highest Education
Medium
v Highest Education
High
EPIPorto −0.83 0.79 0.67 0.60 1.01
Whitehall 0.12 0.11 0.15 0.23 0.00
SKIPOGH 0.44 −0.08 0.25 0.38 0.34
TILDA 0.25 0.21 0.42 −0.10 0.39
ELSA 0.41 0.24 0.56 0.48 0.23
BMI Overweight
v Healthy Weight
EPIPorto 0.49 0.56 −0.03 0.07 0.38
Whitehall 0.56 0.65 0.66 0.66 0.63
SKIPOGH 0.50 0.66 0.39 0.36 0.99
TILDA 0.49 0.54 0.15 0.47 0.05
ELSA 0.58 0.61 0.63 0.39 0.27
BMI Obese
v Healthy Weight
EPIPorto 1.12 1.83 0.64 0.59 0.59
Whitehall 1.64 1.62 1.63 1.63 1.56
SKIPOGH 1.69 2.24 1.99 1.88 1.53
TILDA 1.49 1.47 1.08 1.32 0.76
ELSA 1.68 1.53 1.57 1.52 1.11
Diabetes Indication
v No Diabetes Ind.
EPIPorto 1.07 0.61 −0.24 −0.03 0.14
Whitehall 1.13 1.01 0.79 0.39 0.98
SKIPOGH 1.29 0.62 0.88 1.78 0.02
TILDA 1.06 0.34 0.40 0.06 0.04
ELSA 0.84 0.35 1.23 −0.07 −0.16
Hypertension
Indicated v
No Hypertension Indicated
EPIPorto 0.69 0.84 0.59 −0.20 0.22
Whitehall 0.37 0.44 0.38 0.35 0.43
SKIPOGH 0.22 −0.10 0.18 0.12 0.16
TILDA 0.61 0.16 −0.14 −0.10 −0.29
ELSA 0.09 0.36 0.50 0.20 0.32
Smoked but Quit
EPIPorto −0.54 −0.62 −0.49 −1.30 −0.73
Whitehall 0.07 0.04 0.09 −0.04 0.05
SKIPOGH −0.29 0.06 −0.25 0.44 0.11
TILDA 0.23 −0.03 0.10 0.38 0.05
ELSA −0.12 −0.04 0.04 0.10 0.08
Daily Smoker
EPIPorto 0.18 0.87 0.41 −0.48 1.06
Whitehall 0.76 0.67 1.01 0.87 1.78
SKIPOGH −0.22 −0.54 0.15 0.77 0.06
TILDA 0.61 0.53 0.75 0.67 0.21
ELSA
EPIPorto
0.69 0.60 0.85 0.84 0.49
Female v Male
0.62 0.46 0.39 0.89 1.04
Whitehall 0.35 0.42 0.54 0.56 0.99
SKIPOGH 0.56 −0.09 0.15 0.10 0.34
TILDA 0.35 0.25 0.12 −0.09 0.33
ELSA 0.27 0.18 0.24 0.20 0.33
Table 2. Observed (Unweighted) Mean Deviation in CRP Concentration (mg/L) by Characteristic, Study and 
Age Group. Key: Bold Alone - P < 0.05; Italic Alone - P < 0.01; Bold & Italic: P < 0.001.
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differences reduce with age and are not significant over the age of 70. Across all of the studies, lower SEP groups 
have a higher mean concentrations of CRP and, as predicted, absolute differentials between low SEP and high SEP 
are largest in Portugal (EPIPorto) and lowest in Switzerland (SKIPOGH).
Across all studies except EPIPorto, low SEP – high SEP differentials in inflammation are highest at age 50 and 
fall thereafter. The finding of decreasing differentials with age mirrors those of other studies internationally and 
support an ‘age as leveller’ process with the health status of surviving members of lower SEP groups converging 
with that of higher SEP groups. US and Finnish studies have previously found significant positive absolute differ-
entials in younger age groups39–41 but diminishing or no differential for older age groups. Results from a recent 
British study are broadly consistent with this pattern although, differentials in CRP by income and education 
increased until age 60 before decreasing thereafter19.
Adjusting for the prevalence of different indicators of health behaviour reduces the country variation in rel-
ative SEP differentials in inflammation but does not fully explain the differential between low and high SEP 
groups. As found in previous studies15,16,19,33, adjustment for BMI across studies reduced differentials the most 
followed by adjustment for current and past smoking. Adjustment for all the lifestyle factors together reduced 
the low/high SEP differential by between 45% and 52%. The importance of BMI as a risk factor for raised levels 
of inflammation has been observed in numerous studies15,16,19,33 and reflects the active role of adipose tissue in 
endocrine function. Excess adipose tissue promotes inflammation due to its role as a store for macrophages42 
Figure 2. Predicted Overall CRP Concentrations by Country and Age Trajectory, (mg/L).
A: Unadjusted B: Adjusted
Mean 95% CI P Value % Increase Mean 95% CI P Value % Increase
EPIPorto
SEP High 2.10 1.72 2.47 Ref. 1.43 1.18 1.67 Ref.
SEP Medium 2.44 2.14 2.74 <0.001 16% 1.59 1.38 1.79 <0.001 11%
SEP Low 2.62 2.40 2.84 <0.001 25% 1.63 1.47 1.79 <0.001 14%
Whitehall II
SEP High 1.72 1.58 1.86 Ref. 1.24 1.15 1.34 Ref.
SEP Medium 2.11 2.01 2.22 <0.001 23% 1.42 1.33 1.50 0.055 14%
SEP Low 2.24 2.09 2.38 <0.001 30% 1.46 1.33 1.59 0.004 17%
SKIPOGH
SEP High 1.64 1.37 1.90 Ref. 1.24 1.03 1.45 Ref.
SEP Medium 1.91 1.63 2.18 <0.001 17% 1.37 1.19 1.56 <0.001 11%
SEP Low 1.90 1.67 2.14 <0.001 16% 1.29 1.13 1.45 <0.001 4%
TILDA
SEP High 2.16 2.06 2.25 Ref. 1.40 1.32 1.48 Ref.
SEP Medium 2.34 2.23 2.45 <0.001 9% 1.51 1.41 1.60 <0.001 8%
SEP Low 2.57 2.48 2.67 <0.001 19% 1.54 1.46 1.63 <0.001 10%
ELSA
SEP High 2.17 2.07 2.27 Ref. 1.41 1.33 1.50 Ref.
SEP Medium 2.32 2.24 2.39 <0.001 7% 1.49 1.41 1.56 <0.001 5%
SEP Low 2.62 2.52 2.71 <0.001 21% 1.59 1.50 1.68 <0.001 12%
Table 3. Predicted C-reactive (mg/L) levels by study and SEP. Predicted values adjust for sex, age, age2 using 
study specific generalized linear models. Panel B adjusts additionally for smoking, indications of hypertension, 
BMI and indications of diabetes.
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and the pro-inflammatory effects of endogenous lipids43,44. A recent meta-analysis found that health behaviours 
mediated between 20% and 26% of the SEP differential in all-cause mortality, between 16 and 33% of the differen-
tial for cardiovascular disorders and between 17 and 29% of the differential for metabolic disorders6. Our results 
suggest a greater role for health behaviours in the development of inflammation, although it could be argued that 
our measures of health behaviours could be caused, at least in part, by the status anxiety process that we have been 
studying. If so, this would imply that we are statistically over-adjusting to a certain extent with these measures.
There are a number of potential limitations to this paper. First, the data available to us have limitations. 
Although we examine the predictions of the status anxiety hypothesis in terms of the impact of country income 
inequality on inflammation, we do not directly measure the mediating variable of status anxiety or psycho-social 
stress. Logically, inflammation at the individual level should vary with perceived status anxiety and the chronic 
stress response. There are no current data available, as far as we are aware, which contain survey measures of sta-
tus anxiety alongside bio-markers of chronic stress (e.g cortisol) and inflammation.
A true test of the status anxiety hypothesis would include longitudinal data at the individual level on status 
anxiety and inflammation (as well as health behaviours and SEP) for a statistical sample of countries which vary 
widely in their levels of income inequality both within country over time and between countries in each time 
period. Such data would permit adjustment for country and individual fixed effects and confounding processes at 
the individual level whilst measuring the change in inflammation associated with a change in country level ine-
quality. Unfortunately, internationally harmonised data on inflammatory markers is still very rare so our analysis 
is confined to four countries with a relatively narrow range in income inequality.
Second, the age range available for analysis was limited by the age range covered by the cohort studies avail-
able. Two of the five studies are older persons’ cohort studies (TILDA & ELSA) which include respondents aged 
50+ thus setting the lower age limit. On the other hand, studies which include younger respondents have smaller 
numbers over the age of 75, limiting our observation period from age 50 to 75. It could be that the pattern of SEP 
differentials in SEP changes after age 75 although this is unlikely.
Third, this study used ESeC social class as the measure of SEP whereas other studies have used income 
and education measures. Past research has shown that income, education and social class have independent effects 
on health and mortality2, although all are correlated. Social class is often regarded as a measure of ‘permanent 
income’ as it tends to be correlated more highly with income averaged over a longer period of time than at any 
one point in time2 and so provides a less volatile measure than cross-sectional measures of income. Education, on 
the other hand, is an important predictor of income but its explanatory value varies widely with employment sta-
tus, age and age cohort. Although CRP concentration varies over shorter periods of time, it is likely that chronic 
inflammatory response is a function of extended exposure to poor social and economic conditions thus social 
Figure 3. (a) Predicted Absolute Differentials (Low SEP – High SEP) in CRP Concentration (mg/L) by Country 
and Age. (b) Predicted Absolute Differentials (Middle SEP – High SEP) in CRP Concentration (mg/L) by 
Country and Age.
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class is more highly correlated than income or education. Analyses of our data using highest education level as the 
SEP measure (available on request) show very similar patterns to the results using social class.
Fourth, this study focuses on CRP alone rather than analysing a range of inflammatory markers. This inevi-
tably narrows the range of conclusions that can be drawn from the study. CRP is an acute phase protein, which 
is produced in response to innate pro-inflammatory cytokines including IL-6 and IL-145,46. Low level elevations 
of CRP have been shown to correlate with childhood exposure to parental neglect47 and to be associated with 
increased risk of cardiovascular disease48,49 and cancer50. Our results are in line with those of other studies which 
have examined a wider set of inflammatory markers19,39–41. CRP is an endpoint of multiple pro-inflammatory 
pathways and does not capture anti-inflammatory pathways which are likely to be very important for the develop-
ment of disease. CRP rises in acute inflammatory states in response to the production of innate immune inflam-
matory cytokines, but in homeostatic conditions, levels of CRP drop once inflammation is resolved51. Chronic 
elevation of CRP levels is therefore strongly indicative of a chronic pro-inflammatory state and persistently ele-
vated CRP is a strong predictor of cardiovascular disease development, independent of traditional risk factors.
Figure 4. (a) Predicted CRP Concentration by Class and Age Trajectory, (mg/L) Portugal. (b) Predicted CRP 
Concentration by Class and Age Trajectory, (mg/L) GB (Whitehall II). (c) Predicted CRP Concentration by 
Class and Age Trajectory, (mg/L) Switzerland. (d) Predicted CRP Concentration by Class and Age Trajectory, 
(mg/L) Ireland. (e) Predicted CRP Concentration by Class and Age Trajectory, (mg/L) GB (ELSA).
Figure 5. (a) Predicted Relative Differentials (Low SEP - High SEP) in CRP Concentration (mg/L) by Country 
and Age. (b) Predicted Relative Differentials (Middle SEP - High SEP) in CRP Concentration (mg/L) by 
Country and Age.
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Fifth, the range of lifestyle indicators available on a harmonised basis was smaller than in other studies where 
detailed measures of diet and physical activity were available19. This means that we should be tentative about 
drawing firm conclusions about the extent to which we have adjusted for differences in lifestyles across studies 
and between social groups. It is likely that a wider or more detailed set of lifestyle indicators would increase the 
degree of attenuation produced and so reduce the residual differential between SEP groups.
Sixth, whilst our analyses suggest the health behaviours cannot account for the SEP differential in inflamma-
tion, this does not imply that the unexplained component should be attributed to solely to direct psycho-social 
processes. This paper could not exclude the role of a long list of other potential mediators between SEP and 
inflammation such as differentials in direct environmental exposures such as pollution, poor housing and micro-
bial and parasitic load.
Methods
Data Sources. LIFEPATH is a Horizon 2020 funded project which aims to investigate the biological path-
ways which explain the differentials in premature ageing across different SEP. A consortium of 15 research teams 
harmonised data from 18 cohort studies from different countries which contained socio-economic, demographic, 
clinical and biological information. Detailed information on the LIFEPATH study and the harmonisation proto-
cols used can be found elsewhere52. Five cohort studies (The English Longitudinal Study of Ageing34 (ELSA), The 
Irish Longitudinal Study of Ageing36 (TILDA), The Whitehall II Study35, The Swiss Kidney Project on Genes and 
Hypertension37 (SKIPOGH) and the EPIPorto Study38, all of which included data on the required variables: ESeC 
social class, CRP, age, sex, smoking, indications for diabetes, indications for hypertension and body mass index 
for individuals aged between 50 and 75. Overall, data on 18,349 individuals and 30,632 observations of CRP were 
available for analysis. Summary information on study design, years of recruitment and ethics review is available 
in Supplementary Table 1.
Measures
Inflammatory Markers. Inflammation was measured using CRP in mg/L using a high-sensitivity assay 
across all of the five studies. Multiple observations per person were available for Whitehall II, SKIPOGH, ELSA. 
CRP is extensively used as a biomarker clinically and in epidemiologic studies to define systemic inflammation.
Socio-economic Position. Both individual social class and highest educational level were harmonised 
across the five studies. Social class was harmonised using the European Socio-Economic Classification (ESeC) 
which measures the individuals employment position within labour markets and production units based on a 
ten group classification53. For this paper, these ten groups have been collapsed to three groups: professional and 
managerial class; intermediate class; manual working class referred to as low, medium and high SEP. Educational 
qualifications across the four countries have been harmonised using the International Standard Classification of 
Education (ISCED 2011) and collapsed into three groups: lower secondary education or less; upper secondary 
education; third level education.
Body Mass Index. Data from measured heights and weights was used to calculate body mass index using 
weight(kg)/height(m2) which was divided into underweight (<18.5), healthy (18.5–24.9), overweight (25–29.9) 
and obese (30+).
Smoking. Current and past smoking behaviour was divided into three categories: never smoked (1), past 
smoker (2) and current smoker (3).
Diabetes. Information on reported diagnosis by a clinician, reported diabetes medications and HbA1c meas-
ures were combined to produce a measure of diabetes. Respondents with a previous diagnosis, or who were cur-
rently prescribed medications of Anatomic Therapeutic Classification (ATC) codes ‘A10A’ for insulin and ‘A10B’ 
for oral ant-glycaemic medications or with a HbA1c of >=6.5% were defined as diabetic.
Hypertension. Hypertension was defined as having an SBP >=140 mmHg and DBP >=90 mmHg or 
reported diagnosis by a clinician of high blood pressure or current use of any antihypertensive medication.
Figure 6. Predicted Reduction in Low/High SEP Differential by Adjustment of Lifestyle Factors by Country.
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Gender and Age. Age and gender are used to adjust for demographic composition. Age is used in categorical 
form in descriptive tables (50–54, 55–59, 60–64, 65–69, 70–75) and in continuous form in statistical modelling.
Statistical analyses. Observed differentials in mean CRP by SEP, demographic, socio-economic and 
lifestyle indicator by age group and study were computed and statistical differences identified. Given previous 
research, overall mean concentrations of CRP by study and SEP will be determined by the sex, age and SEP 
distribution of the data and Table 1 provides evidence that these vary widely across the samples. To ensure that 
results do not reflect the composition of the samples, sample weights were designed which force each sample to 
replicate the sample composition of the ELSA sample by sex, age group and social class group. Sample composition 
is therefore identical across studies so variation between samples in CRP concentration cannot reflect variation in 
the sex, age or SEP composition of the sample.
CRP has a strong positive skew in all studies which makes it unsuitable for analysis using ordinary least 
squares regression. Instead, generalised linear models were employed which allow the conditional variance and 
link functions to be chosen which provide the best fit for the data. The modified Park test was used to select the 
former and Hosmer-Lemeshow test used to select the latter. Tests showed that the CRP distributions across all 
five studies was best modelled using Poisson GLM with log link. Individuals within the sample had a minimum 
of one and a maximum of three observations of CRP. The pooled sample across five studies contains at least one 
CRP observation on 19,018 individuals. Only individuals with at least one non-missing observation of CRP were 
retained for analysis but across study waves 30,632 observations were available for analysis as some individu-
als have multiple observations. Robust standard errors are used to adjust for the within individual correlation 
with observations. Missing data on all predictor variables was imputed using chained-equations implemented in 
STATA 15.
‘Base Models’ were estimated with terms for sex, age, study and SEP (measured as ESeC social class). To allow 
for flexible associations of age with CRP, different age polynomials were tested with quadratic and cubic age pol-
ynomial terms providing the best statistical fit based on reduction in log-likelihood. To allow for variation in the 
association between age and CRP across studies, interactions between study and both age, age2 and age3 were esti-
mated. A second model tested for interactions between study, SEP, age and age polynomials to establish whether 
the SEP gradient varied across studies. In a third step, models were estimated to test whether SEP gradients in 
CRP could be explained by lifestyle variables. Measures for smoking, BMI, diabetes and hypertension were added 
separately and together to establish their individual and joint attenuating effects on the SEP/CRP association. 
Pooled models including both sexes were estimated but Interactions between gender and age were included to 
account for gender variation in the association between age and CRP.
Ethical and regulatory approval. All of the data used in this paper were collected with ethical approval 
from the research ethics body of the institution involved. Details of the ethics body for each study are provided 
in Supplementary Table 1. Ethics review in each instance included scrutiny of the protocols and procedures fol-
lowed for the collection of the biological samples and physical measures used in each study. The authors confirm 
that each study was carried out with the full informed consent of all subjects, that only adults aged 18 plus were 
included and that all human tissue was collected in accordance with relevant guidelines and regulations.
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